CRISPR Therapeutics News

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

May 8 16:22 ET

CRISPR Therapeutics | DEF 14A: Definitive information statements

Apr 9 16:47 ET

CRISPR Therapeutics | DEFA14A: Others

Apr 9 16:46 ET

CRISPR Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 27 16:36 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21 07:50 ET

CRISPR Therapeutics | 8-K: Current report

Feb 13 22:28 ET

CRISPR Therapeutics | 8-K: Current report

Feb 13 06:34 ET

CRISPR Therapeutics | 8-K: Current report

Jan 16 00:00 ET

CRISPR Therapeutics | 8-K: Current report

Dec 19, 2023 16:23 ET

CRISPR Therapeutics | 8-K: Current report

Dec 15, 2023 08:58 ET

CRISPR Therapeutics | 8-K: Current report

Dec 13, 2023 09:22 ET

CRISPR Therapeutics | 8-K: Current report

Dec 8, 2023 13:16 ET

CRISPR Therapeutics | 8-K: Current report

Dec 4, 2023 16:26 ET

CRISPR Therapeutics | 8-K: Current report

Nov 16, 2023 07:21 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

Nov 6, 2023 16:33 ET

CRISPR Therapeutics | 8-K: Current report

Sep 7, 2023 08:39 ET

CRISPR Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 7, 2023 16:18 ET

CRISPR Therapeutics | 8-K: Current report

Aug 7, 2023 16:07 ET

CRISPR Therapeutics | 8-K: Current report

Jun 9, 2023 16:29 ET

CRISPR Therapeutics | 8-K: Current report

Jun 9, 2023 07:07 ET